Article info
PDFHeart review
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients
- Correspondence to:
Professor Allan D Struthers
Division of Medicine & Therapeutics, Ninewells Hospital, Dundee DD1 9SY, UK; a.d.struthers{at}dundee.ac.uk
Citation
Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients
Publication history
- Accepted November 16, 2005
- First published December 9, 2005.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Heart